Page last updated: 2024-11-02

pindolol and Liver Cirrhosis

pindolol has been researched along with Liver Cirrhosis in 6 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"The elimination of pindolol was studied in 32 patients suffering from various liver diseases, mainly acute hepatitis and hepatic cirrhosis."3.66Elimination of pindolol in liver disease. ( Meier, J; Münch, U; Ohnhaus, EE, 1982)
" However, the elimination half-life was 6."1.28Pharmacokinetics after a single oral dose of bopindolol in patients with cirrhosis. ( Branch, RA; Humbert, H; Kirch, W; Ohnhaus, EE; Wensing, G, 1990)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wink, K1
Ohnhaus, EE3
Münch, U2
Meier, J2
Braillon, A2
Gaudin, C1
Poo, JL1
Moreau, R1
Debaene, B1
Lebrec, D2
Wensing, G1
Branch, RA1
Humbert, H1
Kirch, W1
Calès, P1

Other Studies

6 other studies available for pindolol and Liver Cirrhosis

ArticleYear
Acute and chronic effects of the beta-receptor blocker mepindolol on hemodynamics and the portal circulation.
    International journal of clinical pharmacology, therapy, and toxicology, 1984, Volume: 22, Issue:8

    Topics: Adult; Blood Pressure; Female; Hemodynamics; Humans; Liver Cirrhosis; Male; Middle Aged; Pindolol; P

1984
Elimination of pindolol in liver disease.
    European journal of clinical pharmacology, 1982, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Aged; Antipyrine; Female; Half-Life; Humans; Kinetics; Liver Cirrhosis; Liver Dis

1982
[Comparative study on the elimination of pindolol (visken) and antipyrin in patients with liver diseases].
    Schweizerische medizinische Wochenschrift, 1976, Dec-04, Volume: 106, Issue:49

    Topics: Antipyrine; Fatty Liver; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Pindolol

1976
Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis.
    Hepatology (Baltimore, Md.), 1992, Volume: 15, Issue:1

    Topics: Epinephrine; Heart Rate; Hemodynamics; Humans; Isoproterenol; Liver Cirrhosis; Male; Middle Aged; No

1992
Pharmacokinetics after a single oral dose of bopindolol in patients with cirrhosis.
    European journal of clinical pharmacology, 1990, Volume: 39, Issue:6

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Hydrolysis; Liver Ci

1990
Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    International journal of clinical pharmacology research, 1985, Volume: 5, Issue:4

    Topics: Adult; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male;

1985